Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option-Reference-Cited by-同舟云学术

Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option

Published:2007-01-18 Issue:2 Volume:23 Page:357-368
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Cornes Paul¹,Coiffier Bertrand²,Zambrowski Jean-Jacques³

Affiliation:

1. Bristol Haematology & Oncology Centre, Horfield Road, Bristol, UK

2. Hematology Department, CH Lyon-Sud, Pierre-Bénite, France

3. Internal Medicine Department, CHU Bichat AP-HP, Paris, and Faculty of Pharmaceutical and Biological Sciences, Université René‑Descartes‑Paris‑5, Paris, France

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079906X167282

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Single 60.000 IU Dose of Erythropoietin Does Not Improve Short-Term Aerobic Exercise Performance in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial;Frontiers in Physiology;2020-09-29

2. Discovery of Clinical Candidate (5-(3-(4-Chlorophenoxy)prop-1-yn-1-yl)-3-hydroxypicolinoyl)glycine, an Orally Bioavailable Prolyl Hydroxylase Inhibitor for the Treatment of Anemia;Journal of Medicinal Chemistry;2020-07-28

3. Allogenic Blood Transfusion is Associated with Poor Perioperative and Long-Term Outcome in Esophageal Cancer;World Journal of Surgery;2016-10-11

4. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model;Health Technology Assessment;2016-02

5. Prise en charge de l’anémie chimio-induite dans le cancer bronchique;Revue des Maladies Respiratoires;2015-10